Research ArticleCancer

Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy

See allHide authors and affiliations

Science Translational Medicine  24 Jun 2020:
Vol. 12, Issue 549, eaba2325
DOI: 10.1126/scitranslmed.aba2325

Article Information

vol. 12 no. 549

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 15, 2019
  • Accepted for publication June 5, 2020
  • .

Author Information

  1. Janelle C. Waite,
  2. Bei Wang,
  3. Lauric Haber,
  4. Aynur Hermann,
  5. Erica Ullman,
  6. Xuan Ye,
  7. Drew Dudgeon,
  8. Rabih Slim,
  9. Dharani K. Ajithdoss,
  10. Stephen J. Godin,
  11. Ilyssa Ramos,
  12. Qi Wu,
  13. Erin Oswald,
  14. Patrick Poon,
  15. Jacquelynn Golubov,
  16. Devon Grote,
  17. Jennifer Stella,
  18. Arpita Pawashe,
  19. Jennifer Finney,
  20. Evan Herlihy,
  21. Hassan Ahmed,
  22. Vishal Kamat,
  23. Amanda Dorvilliers,
  24. Elizabeth Navarro,
  25. Jenny Xiao,
  26. Julie Kim,
  27. Shao Ning Yang,
  28. Jacqueline Warsaw,
  29. Clarissa Lett,
  30. Lauren Canova,
  31. Teresa Schulenburg,
  32. Randi Foster,
  33. Pamela Krueger,
  34. Elena Garnova,
  35. Ashique Rafique,
  36. Robert Babb,
  37. Gang Chen,
  38. Nicole Stokes Oristian,
  39. Chia-Jen Siao,
  40. Christopher Daly,
  41. Cagan Gurer,
  42. Joel Martin,
  43. Lynn Macdonald,
  44. Douglas MacDonald,
  45. William Poueymirou,
  46. Eric Smith,
  47. Israel Lowy,
  48. Gavin Thurston,
  49. William Olson,
  50. John C. Lin,
  51. Matthew A. Sleeman,
  52. George D. Yancopoulos,
  53. Andrew J. Murphy* and
  54. Dimitris Skokos*
  1. Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
  1. *Corresponding author. Email: dimitris.skokos{at}regeneron.com (D.S.); andrew.murphy{at}regeneron.com (A.J.M.)

Altmetric

Article usage

Article usage: June 2020 to June 2020

AbstractFullPdf
Jun 2020817120331076

Stay Connected to Science Translational Medicine